Bottom line
LHCVX vs IXJ: the short answer
LHCVX (Lord Abbett Health Care Fund) and IXJ (iShares Global Healthcare ETF) are both mutual funds.
But IXJ is far broader, holding 124 positions to 61 for LHCVX, so beyond the top names it adds exposure LHCVX doesn't have.
IXJ is cheaper at 0.38% vs 0.68% — a difference of $30 a year per $10,000 invested.
Over five years, IXJ returned +6.4% a year vs +4.8% for LHCVX.
Updated Nov 19, 2026
LHCVX vs IXJ side by side
| LHCVX | IXJ | |
|---|---|---|
| Type | Mutual fund | ETF |
| Fund family | Lord Abbett | iShares |
| Category | Health Care Sector | Health Care Sector |
| Expense ratio | 0.68% | 0.38% |
| Annual cost per $10k | $68 | $38 |
| 10-yr cost on $10k (prospectus) | $3,267 | $480 |
| Max front load | 0% | None |
| 12b-1 fee | 0% | 0% |
| 1-yr return | +18.1% | +14.9% |
| 5-yr return (annualized) | +4.8% | +6.4% |
| 10-yr return (annualized) | — | +8.2% |
| Best quarter | — | +13.6% |
| Worst quarter | — | −11.8% |
| Net assets (fund) | $8.6M | $3.8B |
| Number of holdings | 61 | 124 |
| Portfolio turnover | 91% | 2% |
| Returns as of | Dec 31, 2025 | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Holdings overlap
9 of LHCVX's top 25 holdings also appear in IXJ's top 25.
| Holding | LHCVX | IXJ |
|---|---|---|
| Eli Lilly & Co | 10.40% | 10.93% |
| UnitedHealth Group Inc | 5.39% | 4.40% |
| Johnson & Johnson | 4.96% | 7.04% |
| Novartis AG | 4.19% | 3.71% |
| Gilead Sciences Inc | 3.53% | 2.04% |
| CVS Health Corp | 3.33% | 1.71% |
| Thermo Fisher Scientific Inc | 2.31% | 2.42% |
| Vertex Pharmaceuticals Inc | 2.24% | 1.64% |
| AstraZeneca PLC | 1.97% | 3.76% |
Source: SEC Form N-PORT
LHCVX top 10
- Eli Lilly & Co — 10.40%
- UnitedHealth Group Inc — 5.39%
- Johnson & Johnson — 4.96%
- Novartis AG — 4.19%
- Natera Inc — 3.60%
- Gilead Sciences Inc — 3.53%
- CVS Health Corp — 3.33%
- Guardant Health Inc — 2.61%
- Galderma Group AG — 2.60%
- Thermo Fisher Scientific Inc — 2.31%
IXJ top 10
- Eli Lilly And Company — 10.93%
- Johnson & Johnson — 7.04%
- Abbvie Inc. — 5.12%
- Unitedhealth Group Incorporated — 4.40%
- Merck & Co., Inc. — 4.12%
- Astrazeneca Plc — 3.76%
- Roche Holding AG — 3.75%
- Novartis AG — 3.71%
- Amgen Inc. — 2.54%
- Thermo Fisher Scientific Incorporated — 2.42%
FAQ
What is the difference between LHCVX and IXJ?
Which is cheaper, LHCVX or IXJ?
Should I own both LHCVX and IXJ?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.